Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053)
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program
Brunswick Exploration Drills 36 Meters at 1.51% and Continues to Extend the Mineralized Footprint of Mirage
